Paper: Inhalable N-acetylcysteine dry powder formulations as potential adjuvant treatment for COVID-19
Alessandra Rossi graduated in Chemistry at the University of Pavia (Italy). She spent 6 months as Research Fellow at the University of Gent (Gent, Belgium) and from 1994-1998 she did her PHD at University of Strathclyde (Glasgow, U.K.) in the Department of Pure and Applied Chemistry and in the 1998 she had a Postdoc Research Fellowship from Novartis at Heriot-Watt University (Edinburgh, U.K.).
She is Associate Professor at the Department of Food and Drug, University of Parma and Departmental Delegate for the International Mobility. In 2010 and 2011 she was Invited as Professor at University of Claude Bernard Lyon1 (France), Faculty of Pharmacy.
In 2015 – 2019 she has been Management Committee Member of COST Project MP1404 “Simulation and pharmaceutical technologies for advanced patient-tailored inhaled medicines (SimInhale)” and Leader of Working Group 1 “Particle engineering/processing of inhaled medicines for local/systemic action”.
In 2018 she obtained the National Scientific Qualification for Full Professor
The research interests are mainly focused on pulmonary delivery, in particular in the development of dry powder formulations and testing of nebulizers, and on oral delivery of swellable matrices for drug delivery control, fixed dose combination products and multiparticulate systems.
She collaborates with several international institutions and pharmaceutical companies in the development of medicinal products. She is author of more than 60 peer scientific papers on international peer journals, 8 patents, 4 book chapters and several oral and poster communications to international congress.